The Sandhoff Disease Therapeutics Market is expected to growing at a CAGR of 6% during the forecast period of 2022 to 2028. Sandhoff disease (also called beta-hexosaminidase-beta-subunit deficiency) is a rare, hereditary lipid storage disorder caused by a deficiency of the enzyme beta-hexosaminidase in the brain or other organs. This persistent lipid accumulation affects the […]
